Tengyue Zeng

431 total citations
19 papers, 289 citations indexed

About

Tengyue Zeng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Tengyue Zeng has authored 19 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Tengyue Zeng's work include Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Prostate Cancer Treatment and Research (3 papers). Tengyue Zeng is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Prostate Cancer Treatment and Research (3 papers). Tengyue Zeng collaborates with scholars based in China and United States. Tengyue Zeng's co-authors include Weizhen Wu, Shunliang Yang, Min Liao, Libing Zhu, Dong Wang, Weipeng Su, Qijie Zhang, Ninghong Song, Hu Zhao and Yi Wang and has published in prestigious journals such as Sensors and Actuators B Chemical, Journal of Cellular Physiology and Talanta.

In The Last Decade

Tengyue Zeng

18 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tengyue Zeng China 10 194 144 121 36 27 19 289
Zhousan Zheng China 10 255 1.3× 153 1.1× 64 0.5× 58 1.6× 15 0.6× 16 347
Mirella S. Vredenbregt‐van den Berg Netherlands 5 354 1.8× 258 1.8× 80 0.7× 29 0.8× 26 1.0× 5 406
Karoliina Stefanius United States 8 279 1.4× 181 1.3× 126 1.0× 104 2.9× 20 0.7× 9 402
Ghazal Haddad Canada 7 141 0.7× 82 0.6× 53 0.4× 68 1.9× 24 0.9× 8 223
Edward Geeurickx Belgium 5 241 1.2× 184 1.3× 51 0.4× 42 1.2× 38 1.4× 7 305
Fujiang Xu China 7 180 0.9× 92 0.6× 96 0.8× 49 1.4× 10 0.4× 13 281
Zhimin Mu China 9 309 1.6× 230 1.6× 66 0.5× 61 1.7× 18 0.7× 10 377
Pedro Fonseca Sweden 6 280 1.4× 159 1.1× 48 0.4× 50 1.4× 45 1.7× 12 348
Tianliang Xia China 12 241 1.2× 125 0.9× 81 0.7× 119 3.3× 12 0.4× 21 366

Countries citing papers authored by Tengyue Zeng

Since Specialization
Citations

This map shows the geographic impact of Tengyue Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tengyue Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tengyue Zeng more than expected).

Fields of papers citing papers by Tengyue Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tengyue Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tengyue Zeng. The network helps show where Tengyue Zeng may publish in the future.

Co-authorship network of co-authors of Tengyue Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Tengyue Zeng. A scholar is included among the top collaborators of Tengyue Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tengyue Zeng. Tengyue Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zeng, Tengyue, et al.. (2025). National analysis of the dietary index for gut microbiota and kidney stones: evidence from NHANES (2007–2018). Frontiers in Nutrition. 12. 1540688–1540688. 2 indexed citations
2.
Zhang, Qijie, Junpeng Deng, Tengyue Zeng, et al.. (2025). Prone versus lateral retroperitoneoscopic partial nephrectomy for posterior tumors in adults: technique and clinical outcomes. Translational Andrology and Urology. 14(3). 567–577. 1 indexed citations
3.
Li, Quan, Qijie Zhang, Hua Shen, et al.. (2025). Laparoscopic Resection of a Rare Retroperitoneal Dermoid Cyst in a 78-Year-Old Woman: A Case Report. American Journal of Case Reports. 26. e947666–e947666.
4.
Wu, Lei, Jiajie Liang, Yong He, et al.. (2024). A filter pad design-based multiplexed lateral flow immunoassay for rapid simultaneous detection of PDCoV, TGEV, and PEDV in swine feces. Talanta. 280. 126712–126712. 3 indexed citations
5.
Deng, Junpeng, Tengyue Zeng, Qi‐Jie Zhang, et al.. (2024). Associations between inflammatory burden index, prostate cancer, and mortality among middle-aged and elderly individuals. World Journal of Urology. 42(1). 538–538. 1 indexed citations
7.
Liang, Jiajie, Lei Wu, Yaqi Wang, et al.. (2023). SERS/photothermal-based dual-modal lateral flow immunoassays for sensitive and simultaneous antigen detection of respiratory viral infections. Sensors and Actuators B Chemical. 389. 133875–133875. 26 indexed citations
9.
Zeng, Tengyue, et al.. (2021). Identification and validation of a five apoptosis-related genes signature for prediction of disease-free survival for testicular germ cell tumors. Translational Andrology and Urology. 10(3). 1250–1272. 4 indexed citations
10.
Xing, Qianwei, Tengyue Zeng, Shouyong Liu, et al.. (2021). A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. BMC Cancer. 21(1). 381–381. 29 indexed citations
11.
Luan, Jiaochen, Qijie Zhang, Kai Zhao, et al.. (2021). A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy. Journal of Cancer. 12(12). 3715–3725. 11 indexed citations
12.
Luan, Jiaochen, Tengyue Zeng, Qijie Zhang, et al.. (2021). A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration. Cancer Cell International. 21(1). 414–414. 23 indexed citations
13.
Zhao, Kai, Qijie Zhang, Tengyue Zeng, et al.. (2021). Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer. Translational Andrology and Urology. 10(3). 1229–1240. 17 indexed citations
14.
15.
Zhao, Hu, et al.. (2018). Cell fate regulation by reticulon‐4 in human prostate cancers. Journal of Cellular Physiology. 234(7). 10372–10385. 9 indexed citations
16.
Su, Weipeng, Lina Sun, Shunliang Yang, et al.. (2018). Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro. Journal of Biochemical and Molecular Toxicology. 32(7). e22158–e22158. 32 indexed citations
17.
Lai, Xiaofeng, Weipeng Su, Hu Zhao, et al.. (2018). Loss of scinderin decreased expression of epidermal growth factor receptor and promoted apoptosis of castration‐resistant prostate cancer cells. FEBS Open Bio. 8(5). 743–750. 10 indexed citations
18.
Zeng, Tengyue, Libing Zhu, Min Liao, et al.. (2017). Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer. Medical Oncology. 34(2). 27–27. 75 indexed citations
19.
Wang, Dong, Libing Zhu, Min Liao, et al.. (2016). MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40. Oncology Reports. 36(3). 1285–1292. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026